Articles |
From the Department of Medicine (S.-J.K., B.G., R.K.K., C.-H.H., S.F.V.), Harvard Medical School and Brigham and Women's Hospital, Boston, Mass; the New England Regional Primate Research Center (S.-J.K., B.G., R.K.K., C.-H.H., S.F.V.), Southborough, Mass; the Cardiovascular Research Institute (S.-J.K., B.G., R.K.K., C.-H.H., S.F.V.), Allegheny University of the Health Sciences, Pittsburgh, Pa; and New York Medical College (T.H.H.), Department of Physiology, Valhalla, NY.
Correspondence to Stephen F. Vatner, MD, George J. Magovern Professor, and Director, Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, 15th Floor South Tower, 320 East North Ave, Pittsburgh, PA 15212.
| Abstract |
|---|
|
|
|---|
Key Words: ischemia coronary circulation endothelium nitric oxide stunning
| Introduction |
|---|
|
|
|---|
Interestingly, there is no information available on the delayed effects of brief periods of ischemia on endothelial function of the coronary circulation. This may be due to the fact that most previous studies used acute preparations, which are not suitable for studying long periods after the initial ischemic insult. Thus, the present investigation is unique in examining both the early and delayed effects (up to 5 days) of brief periods (10 minutes) of myocardial ischemia on coronary endothelial function in chronically instrumented conscious dogs. Another important aspect of the experimental design is the utilization of a chronically implanted intracoronary catheter, which minimizes alterations of hemodynamic factors and concomitant changes in myocardial oxygen demand and in neurohumoral reflexes induced by the intravenous administration of drugs. Once it was established that brief periods of myocardial ischemia induced delayed enhanced vasodilator responses to intracoronary ACh and BK, endothelial vasodilators, the second goal was to determine whether the enhanced vasodilation resulted in the appearance of increased levels of NO in the coronary sinus effluent. The third goal of the present study was to determine whether these effects could be attenuated either by administration of an NO synthesis inhibitor9 or by preventing the hyperemia during early CAR, which would provide information on the mechanism of the delayed enhanced endothelial function, ie, whether it was triggered by the period of ischemia or by increased shear stress associated with the marked hyperemia characteristic of early CAR.
| Materials and Methods |
|---|
|
|
|---|
3 cm; care was taken not to damage the vessel
adventitia and surrounding nerves.10 11 A Transonic
transit time flow probe (Transonic Systems Inc) was implanted around
the base of the left circumflex artery for measurement of CBF, and a
hydraulic occluder was placed distal to the flow probe to occlude the
coronary artery. A coronary arterial
catheter was implanted distal to the occluder in 11 of the 14 dogs.
Another Silastic catheter was inserted into the coronary sinus
for myocardial venous blood sampling. Two pairs of 5-mHz ultrasonic
crystals were implanted transmurally across the LV free wall in the
anterior and in the posterior regions for measurement of regional
myocardial wall thickening.
|
After the surgical preparation was completed, the catheters, occluder, and the lead wires were tunneled under the skin to exit between the scapula. The ribs were approximated, the incision was closed in layers, and the thoracic cavity was evacuated. Antibiotics and analgesics were given for 5 days or as needed. The indwelling catheters were flushed daily with heparinized saline to maintain patency. Animals used in the present study were maintained in accordance with the guidelines of the Committee on Animals of the Harvard Medical School and the Guide for the Care and Use of Laboratory Animals (Department of Health and Human Services Publication No. [NIH] 85-23, revised 1985).
Experimental Measurements
Aortic and left atrial pressures were measured with Statham
strain-gauge transducers (model P23-XL, Spectra-Med, Inc), which were
calibrated using a mercury manometer. A cardiotachometer (Beckman),
triggered by the LV pressure pulse, provided a continuous
recording of heart rate. LV dP/dt was derived from the LV
pressure signals using an electronic differentiator. The solid-state LV
pressure gauge was cross-calibrated against measurements of
systolic aortic and left atrial pressures. During each
experiment, hemodynamic variables were recorded
continuously both on a multichannel tape recorder (Honeywell) and
played back on a direct-writing oscillograph (Gould). Regional
myocardial blood flow was measured before and during CAO with
radioactive labeled microspheres (15±2 µm, New England
Nuclear).
Plasma levels of NO metabolites, nitrate (NO3-), and nitrite (NO2-), an index of endothelium-derived NO, were measured as previously described.12 Dogs were fasted for >12 hours before the experiments so that dietary NO3- would not affect the serum levels of NO3-.13 Briefly, duplicate blood samples (each 4 mL) were obtained from the aorta and coronary sinus in heparinized tubes. The blood was centrifuged at 4000g for 20 minutes, and then the plasma was frozen for at least 24 hours before analysis. For measurement of plasma nitrate plus nitrite, nitrate was reduced to nitrite by adding to each tube 10 µL (0.2 U) Aspergillus nitrate reductase (reconstituted in distilled water as 20 U/mL), 10 µL (0.1 µmol) flavin adenine dinucleotide, and 10 µL (0.1 µmol) reduced NADP (Boehringer-Mannheim Biochemicals). Tubes were capped immediately with a rubber septum (Suba-Seal Septa, Aldrich Chemical Co), and the oxygen in the headspace above the sample was removed and replaced with argon. Samples were incubated at 36°C for 1 hour under the inert argon atmosphere to allow conversion of nitrate to nitrite. After incubation, 40 µL concentrated HCl was added through the seal to each reaction tube to achieve a pH <2. Tubes were incubated for an additional 5 minutes at 36°C. A 250-µL sample of the headspace gas was removed from the sealed tubes at the end of the incubation and injected into the NO analyzer to quantify the NO released into the headspace gas. Standard curves for nitrate were constructed. To calculate the intra-assay coefficient of variation, the basal nitrate and nitrite in each assay were run in triplicate, and the differences were compared.
Experimental Protocol
At least 10 to 14 days of recovery from surgery was allowed
before experimentation was begun. During this period, dogs were trained
to lie quietly on the table. Hemodynamic variables
(aortic pressure, LV pressure, left atrial pressure, rate of change of
LV pressure [dP/dt], LV anterior and posterior wall thicknesses,
heart rate, and lead II ECG) were monitored continuously throughout the
study. All animals received an injection of morphine sulfate (0.2 mg/kg
IM) before CAO. After control measurements were recorded, including
the first injection of microspheres, CAO was accomplished by
inflating the hydraulic occluder. At 5 minutes after CAO,
microspheres were injected again. Ventricular
premature contractions were prevented and treated with bolus left
atrial injections of 2% lidocaine. After 10 minutes of CAO, the
coronary artery occluder was released slowly over 30 seconds.
Hemodynamic variables during CAR were monitored
continuously for 6 hours and then at 1, 2, and 5 days, until full
recovery of regional myocardial and vascular function.
To determine the magnitude and duration of altered endothelial or nonendothelial coronary vascular reactivity after 10 minutes of occlusion and 5 days of reperfusion, the direct coronary effects of ACh and BK, endothelium-dependent vasodilators, and SNP, an endothelium-independent vasodilator, were investigated in each of the 8 dogs at the following infusion rates: (1) ACh (10 µg/min), (2) BK (2.5 µg/min), and (3) SNP (40 µg/min). The concentrations of these vasodilators were formulated so that an identical infusion rate was used for each drug (0.5 mL/min). The low infusion rate and concentrations were selected to avoid both hemodilution and systemic effects secondary to recirculation. The order of the intracoronary infusions was randomized by drug, and at least 15 minutes intervened between each intracoronary infusion to permit recovery and acquisition of predrug control values before the subsequent infusion. The responses to intracoronary vasodilators were assessed before CAO (baseline) and after 30 minutes, 1 hour, 3 hours, 6 hours, 1 day, 2 days, and 5 days of reperfusion. At baseline and after 1 day of reperfusion, blood samples from the aorta and coronary sinus were taken to determine oxygen content and measurement of NO metabolites at steady-state condition during infusion of each vasodilator from respective control conditions. Coronary reactive hyperemia was determined after the release of a 15-second CAO at baseline and after 30 minutes and 1 day of reperfusion.
To determine whether the enhanced endothelial function following 10-minute coronary occlusion could be attenuated or prevented by treatment with an NOS inhibitor, L-NA was administered (2 mg/min IC for 25 minutes) in 3 additional dogs at least 12 hours before CAO, 30 minutes before CAO, and after 1 day of CAR, and then the responses to the vasodilators were repeated during reperfusion (see above). L-NA was dissolved in saline after 20 to 30 minutes of sonication as described by Moore et al.9 There was no significant change in baseline CBF between preand postL-NA values (32±7 vs 28±7 mL/min) (n=3).
To determine whether the delayed enhanced endothelial function could be eliminated by preventing the marked increase in CBF following the release from the 10-minute CAO, in 3 of the original 8 dogs studied, the occluder was deflated until CBF reached pre-CAO levels during the initial reperfusion period and was maintained at pre-CAO levels. During reperfusion, the protocol for the intracoronary infusion of vasodilators was repeated (see above).
To determine whether the intracoronary catheter was responsible for the enhanced endothelial function, in 3 dogs without an intracoronary catheter the protocol was conducted with intravenous administration of ACh (3 µg/kg) and SNP (4 µg/kg).
An additional 4 dogs were instrumented but were not included in the data analysis because of ventricular fibrillation during the 10-minute CAO.
Data Analyses
Data are reported as mean±SE. Differences between means were
considered statistically significant if the probability of their
occurring by chance was <5% (P<.05). For all comparisons,
data within and among the protocols were analyzed for
statistical significance using one-way ANOVA for repeated measures,
contrast analysis for individual comparisons, and Student's
t test for paired data (baseline versus 1-day CAR, left
circumflex territory [ischemic zone] versus left anterior
descending territory [nonischemic zone], and presence versus
absence of NO blockade).14
| Results |
|---|
|
|
|---|
|
|
CBF Responses to Vasodilators
Intracoronary infusions of ACh, BK, and SNP caused
significant increases in CBF without any changes in systemic
hemodynamics. Fig 4
depicts a
representative tracing of CBF during
intracoronary infusion of ACh and BK at baseline and after 3
hours, 6 hours, 1 day, 2 days, and 5 days of CAR, demonstrating
enhanced coronary vasodilation to both
endothelial vasodilators after 1 and 2 days of CAR. Fig 5
summarizes CBF response to these vasodilators before
CAO and during CAR. The 10-minute ischemic episode induced a
biphasic effect on coronary endothelial
function (Fig 5
). Initially, the endothelium-dependent
coronary vasodilator response to ACh was depressed
significantly at 30 minutes after CAR (-19±8%) (P<.05).
In contrast, endothelium-dependent coronary
vasodilator responses to both ACh and BK began to increase after 6
hours of reperfusion, with a maximum vasodilator response 1 to 2 days
later, and then subsided over the subsequent 4 days, as shown in Figs 4
and 5
. After 1 day of CAR, CBF responses to ACh and BK were increased
significantly compared with pre-CAO baseline responses (from 106±12%
to 174±25% and from 105±13% to 174±21%, respectively)
(P<.05), whereas there were no significant differences in
endothelium-independent vasodilator response to SNP
(Fig 5
). In brief, SNP increased CBF from 34±3 to 58±2 mL/min before
CAO and, similarly, from 32±4 to 57±2 mL/min after 10-minute CAO and
24-hour CAR.
|
|
To determine whether the enhanced endothelium-dependent coronary vasodilator response observed after 1 to 2 days of CAR was partially due to inadvertent side effects of the intracoronary catheter, a bolus dose of ACh (3 µg/kg) was given intravenously to 3 dogs without chronic intracoronary catheters before CAO and after 1 day of CAR. After 1 day of CAR, CBF responses to intravenous ACh were also increased significantly from 149±12% to 212±34% (P<.05). After 5 days of CAR, the response to ACh returned to pre-CAO levels. This indicates that the intracoronary catheter was not responsible for the enhanced endothelium-dependent coronary vasodilator responses after 1 to 2 days of CAR. Holding coronary flow to pre-CAO levels during the initial reperfusion period in 3 dogs did not prevent the delayed, enhanced (P<.05), endothelium-dependent vasodilator responses to both ACh (from 98±3% to 186±50%) and BK (from 89±13% to 155±56%), but not SNP, after 1 day of CAR.
Reactive Hyperemia at Early and Late Reperfusion
Table 1
summarizes changes in peak flow and
peak/baseline flow and repayment/debt ratio before CAO and after 30
minutes and 1 day of CAR following 10-minute CAO (n=5). At 30 minutes
after CAR, peak reactive hyperemia and the ratio of
peak/baseline and repayment/debt were significantly reduced (-23±8%,
-19±7%, and -30±11%, respectively) (P<.05). In
contrast to the depressed response after 30 minutes of CAR, these
values were increased significantly after 1 day of CAR (+23±5%,
+16±9%, and +30±4%, respectively) (P<.05).
|
Coronary Arteriovenous O2 Content and NO
Metabolites
Table 2
summarizes the changes in CBF,
arterial and venous oxygen content, and percent changes in
posterior wall thickening during intracoronary infusion of ACh,
BK, and SNP at baseline and after 1 day of CAR (n=4). After 1 day of
CAR, intracoronary ACh and BK, but not SNP, significantly
increased both CBF and coronary sinus oxygen content compared
with respective pre-CAO responses. However, intracoronary
infusion of vasodilators did not affect posterior wall thickening or
systemic hemodynamics either at baseline or after 1 day
of CAR.
|
Table 3
summarizes the production of NO
metabolites before (n=6) and during (n=3) intracoronary
infusion of BK before CAO (pre-CAO) and after 1 day of CAR. Compared
with pre-CAO values, production of NO metabolites was increased
significantly both at baseline (153±56%) and during BK administration
(220±76%) after 1 day of CAR. Thus, the delayed and enhanced
coronary vasodilation after 1 day of CAR can be explained by an
upregulation of coronary vascular NO production.
|
Responses After Intracoronary L-NA
There were no significant changes in baseline systemic
hemodynamics and CBF before versus after L-NA
administration, verifying that intracoronary L-NA did not
affect systemic hemodynamics. During CAO, mean aortic
pressure, LV systolic pressure, LV end-diastolic
pressure, and heart rate increased significantly, whereas these
variables returned to baseline levels by 30 minutes and did not
change throughout 5 days of CAR. However, L-NA (intracoronary)
caused a significant delay in the recovery of posterior wall thickening
(ischemic zone) following 10-minute CAO (data not shown).
Fig 6
shows an example of CBF responses to ACh and BK
before CAO and after 1 day of CAR in the presence of NO blockade (n=3).
Before 10 minutes of CAO, intracoronary NO blockade with L-NA
caused significantly blunted endothelium-dependent
dilation with ACh (-60±15%) and BK (-61±15%) (P<.05),
but not SNP (-1±12%). After 1 day of CAR, CBF responses to ACh and
BK were not enhanced compared with responses in the presence of NO
blockade (after L-NA), whereas CBF responses to SNP were not different.
In the 3 dogs studied, baseline CBF fell from 32±7 to 28±7 mL/min and
remained at 26±5 mL/min after 1 day of CAR. After L-NA administration,
ACh increased CBF to 53±15 mL/min and by a similar amount (50±11
mL/min) after 1 day of CAR. Similarly, after L-NA administration, BK
increased CBF to 60±15 mL/min and by a similar amount (62±14 mL/min)
after 1 day of CAR.
|
| Discussion |
|---|
|
|
|---|
In contrast to all the previous studies noted above, in the present investigation a 10-minute brief ischemic episode induced a significant increase in endothelium-dependent vasodilation in response to ACh and BK, which was first noted 6 hours after reperfusion, with a maximum response occurring 1 to 2 days later. Importantly, there was an increase in reactive hyperemia as well as endothelium receptormediated vasodilation (responses to ACh and BK). This increased endothelium-mediated vasodilation was primary, not secondary, to increased metabolic demand after 1 day of reperfusion, since coronary sinus oxygen content rose. Furthermore, there were no increases in posterior wall thickening, heart rate, arterial pressure, or hemodynamic factors that would result in coronary vasodilation secondary to increased myocardial metabolic demand. The mechanism of the enhanced vasodilation most likely involved upregulation of NO. In support of this concept, production of NO metabolites (nitrate and nitrite) was significantly increased 1 day after CAO and CAR at both baseline and during BK. Actually, the assessment of NO metabolites in coronary sinus blood may have been underestimated, because of the confluence of drainage from the nonischemic left anterior descending arterial bed. In further support, the experiments with L-NA, which inhibits the production of NO, demonstrated prevention of the enhanced endothelium-mediated coronary vasodilation after 1 day of CAR. Although the increased response after 1 day of CAR was abolished by NO blockade, ACh and BK still elicited some vasodilation, as expected, since L-NA is a competitive inhibitor of NOS.9 19 The experiments with L-NA did demonstrate intensification of the myocardial stunning, which has been shown previously.20 Which NOS of the three was responsible for the enhanced vasodilation was not determined. Endothelial cell NOS (NOS III) is most likely responsible for the enhanced NO production, since inducible NOS (NOS II) evokes substantial baseline arteriolar vasodilation and even hypotension. In addition, another characteristic of inducible NOS is sustained activity resulting in tissue damage,21 features not observed in the present study, where systemic hemodynamics and regional myocardial function were entirely normal after 1 day of CAR following 10-minute CAO. It is also important to consider the possibility that prostaglandins or hyperpolarizing factor may have played a role in the mechanism.22
In view of the delayed onset of the enhanced
endothelium-dependent coronary vasodilation and
its temporal relationship to a 10-minute ischemic
preconditioning stimulus, it is tempting to speculate that the
upregulation of NO production could be involved in the
mechanism of the second window of preconditioning. Murry et
al23 first described preconditioning as a mechanism of
myocardial protection closely following the initial ischemic
stimulus. More recently, a second window of protection has been
described, which occurs
24 hours after the initial ischemic
stimulus.24 25 The time course of the upregulation of NO
production in the present study is consistent with
that of the second window of ischemic preconditioning. In this
connection, a study by Bolli et al26 in this issue of
Circulation Research found that NO blockade prevented the
delayed window of preconditioning against myocardial stunning in
conscious rabbits, which is consistent with the findings in the
present investigation.
The stimulus for the upregulation of NO production could be either the 10-minute period of ischemia or factors involved with reperfusion. For example, Beckman et al27 have proposed that reoxygenation after hypoxia may stimulate rapid NO synthesis by providing the O2 to produce NO, since the intracellular Ca2+ and other substrates (arginine and NADPH) would already be made available by the ischemic insult. Thus, the synthesized NO reacts rapidly with O2- to form peroxynitrite anion (ONOO-) and hydroxyl radical (HO-).27 The present investigation used a model of a brief period of ischemia, rather than hypoxia, which does not result in infarction, but only myocardial contractile stunning was observed after reperfusion. Furthermore, the upregulation of NO production was most likely protective, as it resulted in enhanced coronary vasodilation; when it was blocked with L-NA, intensification of the stunning was observed. Also associated with CAR is a marked hyperemia. It is well known that increases in blood flow velocity can result in augmented endothelium-mediated vasodilation.28 29 Accordingly, we repeated experiments in which the hyperemia was prevented but failed to attenuate the delayed, enhanced, endothelium-mediated coronary vasodilation. For these reasons, the 10-minute period of ischemia, rather than the reperfusion, was most likely the trigger for the upregulation of NO production.
One might argue that the genesis of the NO was derived from myocytes rather from coronary vessels. Although this is theoretically possible, it is unlikely because the vascular response was enhanced, whereas myocardial contractile responses to ACh and BK remained intact. Moreover, preliminary data using a microvascular preparation in vitro also showed enhanced NO metabolites in response to ACh and BK 1 day after 10-minute CAO and after 24 hours of CAR (authors' unpublished data, 1997).
It is possible to speculate that this upregulation of NO-mediated coronary vasodilation is important not only in the second window of protection24 25 but also in coronary autoregulation. The latter phenomenon is composed of multiple mechanisms, all designed to protect the heart by maintaining its blood supply. Whereas the induction of coronary collaterals is a chronic compensatory adjustment to multiple ischemic episodes, it may be that upregulation of NO-mediated vasodilation may be an intermediate mechanism involved in coronary autoregulation.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received March 5, 1997; accepted April 14, 1997.
| References |
|---|
|
|
|---|
2.
Braunwald E, Kloner RA. The stunned
myocardium: prolonged, postischemic
ventricular dysfunction. Circulation. 1982;66:1146-1149.
3.
Bolli R. Mechanism of myocardial
`stunning.' Circulation. 1990;82:723-738.
4.
Dauber IM, VanBenthuysen KM, McMurtry IF, Wheeler GS,
Lesnefsky EJ, Horwitz LD, Weil JV. Functional
coronary microvascular injury evident as increased permeability
due to brief ischemia and reperfusion. Circ Res.. 1990;66:986-998.
5.
Ku DD. Coronary vascular reactivity
after acute myocardial ischemia. Science. 1982;218:576-578.
6. VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest.. 1987;79:265-274.
7. Nicklas J, Gips SJ. Decreased coronary flow reserve after transient myocardial ischemia in dogs. J Am Coll Cardiol.. 1989;13:195-199.[Abstract]
8.
Kim YD, Fomsgaard JS, Heim KF, Ramwill PW, Thomas
G, Kagan E, Moore SP, Coughlin S, Kuwahara M, Analouei A, Myers
AK. Brief ischemia-reperfusion induces stunning of
endothelium in canine coronary artery.
Circulation. 1992;85:1473-1482.
9. Moore PK, al-Swayeh OA, Chong NWS, Evans RA, Gibson A. L-NG-Nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol.. 1990;99:408-412.[Medline] [Order article via Infotrieve]
10. Knight DR, Thomas JX Jr, Randall WC, Vatner SF. Effects of left circumflex coronary flow transducer implantation on posterior wall innervation. Am J Physiol. 1987;252(pt 2):H536-H539.
11.
Denn MJ, Stone HL. Autonomic innervation of dog
coronary arteries. J Appl Physiol.. 1976;41:30-35.
12.
Zeballos GA, Bernstein RD, Thompson CI, Forfia PR,
Seyedi N, Shen W, Kaminski PM, Wolin MS, Hintze TH.
Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric
oxide formation in conscious dogs. Circulation. 1995;91:2982-2988.
13. Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurement of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J Cardiovasc Pharmacol. 1992;20(suppl 12):S214-S216.
14. Zar JH. Biostatistical Analyses. Englewood Cliffs, NJ: Prentice-Hall; 1974.
15. Aoki N, Bitterman ME, Brezinski ME, Lefer AM. Cardioprotective actions of human superoxide dismutase in two reperfusion models of myocardial ischemia in the rat. Br J Pharmacol.. 1988;95:735-740.[Medline] [Order article via Infotrieve]
16.
Johnson G III, Furlan LE, Aoki N, Lefer AM.
Endothelium and myocardial protecting actions of
taprostene, a stable prostacyclin analogue, after acute myocardial
ischemia and reperfusion in cats. Circ Res.. 1990;66:1362-1370.
17.
Mehta JL, Lawson DL, Nichols WW. Attenuated
coronary relaxation after reperfusion: effects of superoxide
dismutase and TxA2 inhibitor U 63557. Am
J Physiol.. 1989;257:H1240-H1246.
18.
Tsao PS, Aoki N, Lefer DJ, Johnson G III, Lefer
AM. Time course of endothelial dysfunction and
myocardial injury during myocardial ischemia and reperfusion in
the cat. Circulation. 1990;82:1402-1412.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev.. 1991;43:109-142.[Medline] [Order article via Infotrieve]
20.
Hasebe N, Shen YT, Vatner SF. Inhibition of
endothelium-derived relaxing factor enhances myocardial
stunning in conscious dogs. Circulation. 1993;88:2862-2871.
21. Nathan C, Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915-918.[Medline] [Order article via Infotrieve]
22.
Cohen RA, Vanhoutte PM.
Endothelium-dependent
hyperpolarization: beyond nitric oxide and cyclic
GMP. Circulation.. 1995;92:3337-3349.
23.
Murry CE, Jennings RB, Reimer KA.
Preconditioning with ischemia: a delay of lethal injury in
ischemic myocardium.
Circulation. 1986;74:1124-1136.
24.
Marber MS, Latchman DS, Walker JM, Yellon DM.
Cardiac stress protein elevation 24 hours after brief ischemia
or heat stress associated with resistance to myocardial
infarction. Circulation. 1993;88:1264-1272.
25.
Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M,
Kamada T, Tada M. Delayed effects of sublethal ischemia
on the acquisition of tolerance to ischemia. Circ
Res.. 1993;72:1293-1299.
26. Bolli R, Bhatti ZA, Tang X-L, Qui Y, Zhang Q, Guo Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res.. 1997;81:956-966.
27.
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman
BA. Apparent hydroxyl radical production by
peroxynitrite: implications for endothelial injury from
nitric oxide and superoxide. Proc Natl Acad Sci
U S A. 1990;87:1620-1624.
28.
Hintze TH, Vatner SF. Reactive dilation of large
coronary arteries in conscious dogs. Circ
Res. 1984;54:50-57.
29. Shen W, Lundborg M, Wang J, Stewart JM, Xu X, Ochoa M, Hintze TH. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs. J Appl Physiol. 1994;77:1165-1172.
This article has been cited by other articles:
![]() |
R. M. Gill, J. C. Braz, N. Jin, G. J. Etgen, and W. Shen Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2782 - H2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, X. Zhang, X. Xu, A. Chen, J. B. Gonzalez, S. Koul, K. Vijayan, G. J. Crystal, S. F. Vatner, and T. H. Hintze Evidence for enhanced eNOS function in coronary microvessels during the second window of protection Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2152 - H2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nikolaidis, A. Doverspike, T. Hentosz, L. Zourelias, Y.-T. Shen, D. Elahi, and R. P. Shannon Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 303 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, M. Kelm, and G. Heusch Nitric oxide in myocardial ischemia/reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 402 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Laude, P. Beauchamp, C. Thuillez, and V. Richard Endothelial protective effects of preconditioning Cardiovasc Res, August 15, 2002; 55(3): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanoue, P. Herijgers, B. Meuris, E. Verbeken, V. Leunens, M. Lox, and W. Flameng Ischemic preconditioning reduces unloaded myocardial oxygen consumption in an in-vivo sheep model* Cardiovasc Res, August 15, 2002; 55(3): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, Y.-K. Kim, G. Takagi, C.-H. Huang, Y.-J. Geng, and S. F. Vatner Enhanced iNOS function in myocytes one day after brief ischemic episode Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H423 - H428. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P. Shannon Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2270 - H2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ebrahim, D. M Yellon, and G. F Baxter Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1458 - H1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Parent De Curzon, B. Ghaleh, R. Tissier, J.-F. Giudicelli, L. Hittinger, and A. Berdeaux Myocardial stunning in exercise-induced ischemia in dogs: lack of late preconditioning Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H302 - H310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kudej, X.-P. Zhang, B. Ghaleh, C.-H. Huang, J. B. Jackson, A. B. Kudej, N. Sato, S. Sato, D. E. Vatner, T. H. Hintze, et al. Enhanced cAMP-induced nitric oxide-dependent coronary dilation during myocardial stunning in conscious pigs Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2967 - H2974. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhao, X. Zhang, X. Xu, M. S. Wolin, and T. H. Hintze Depressed modulation of oxygen consumption by endogenous nitric oxide in cardiac muscle from diabetic dogs Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H520 - H527. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kudej, S.-J. Kim, Y.-T. Shen, J. B. Jackson, A. B. Kudej, G.-P. Yang, S. P. Bishop, and S. F. Vatner Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H451 - H456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Leone Jr., P. M. Scholz, and H. R. Weiss Nitroprusside Attenuates Myocardial Stunning Through Reduced Contractile Delay and Time Experimental Biology and Medicine, March 1, 2000; 223(3): 263 - 269. [Abstract] [Full Text] |
||||
![]() |
Y. Guo, W. K. Jones, Y.-T. Xuan, X.-L. Tang, W. Bao, W.-J. Wu, H. Han, V. E. Laubach, P. Ping, Z. Yang, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene PNAS, September 28, 1999; 96(20): 11507 - 11512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Rakhit, R. J Edwards, and M. S Marber Nitric oxide, nitrates and ischaemic preconditioning Cardiovasc Res, August 15, 1999; 43(3): 621 - 627. [Full Text] [PDF] |
||||
![]() |
J. Zanzinger Role of nitric oxide in the neural control of cardiovascular function Cardiovasc Res, August 15, 1999; 43(3): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S.R. Baker, O. Rimoldi, P. G. Camici, E. Barnes, M. R. Chacon, T. Y. Huehns, D. O. Haskard, J. M. Polak, and R. J.C. Hall Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases Cardiovasc Res, August 15, 1999; 43(3): 685 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takano, S. Manchikalapudi, X.-L. Tang, Y. Qiu, A. Rizvi, A. K. Jadoon, Q. Zhang, and R. Bolli Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits Circulation, August 4, 1998; 98(5): 441 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Rohs, K. S. Kilgore, A. J. Georges, and S. F. Bolling Postischemic Function and Protein Kinase C Signal Transduction Ann. Thorac. Surg., June 1, 1998; 65(6): 1680 - 1684. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bolli, S. Manchikalapudi, X.-L. Tang, H. Takano, Y. Qiu, Y. Guo, Q. Zhang, and A. K. Jadoon The Protective Effect of Late Preconditioning Against Myocardial Stunning in Conscious Rabbits Is Mediated by Nitric Oxide Synthase : Evidence That Nitric Oxide Acts Both as a Trigger and as a Mediator of the Late Phase of Ischemic Preconditioning Circ. Res., December 19, 1997; 81(6): 1094 - 1107. [Abstract] [Full Text] |
||||
![]() |
J. R PARRATT and A. VEGH Delayed protection against ventricular arrhythmias by cardiac pacing Heart, November 1, 1997; 78(5): 423 - 425. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |